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Abstract
Background and objectives
Treatment guidelines do not recommend antibiotic use for acute respiratory infections (ARI),
except for streptococcal pharyngitis/tonsillitis and pneumonia. However, antibiotics are pre-
scribed frequently for children with ARI, often in absence of evidence for bacterial infection.
The objectives of this study were 1) to assess the appropriateness of antibiotic prescriptions
for mild ARI in paediatric outpatients in relation to available guidelines and detected patho-
gens, 2) to assess antibiotic use on presentation using questionnaires and detection in urine
3) to assess the carriage rates and proportions of resistant intestinal Enterobacteriaceae
before, during and after consultation.
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Materials and methods
Patients were prospectively enrolled in Children’s Hospital 1, Ho Chi Minh City, Vietnam and
diagnoses, prescribed therapy and outcome were recorded on first visit and on follow-up
after 7 days. Respiratory bacterial and viral pathogens were detected using molecular
assays. Antibiotic use before presentation was assessed using questionnaires and urine
HPLC. The impact of antibiotic usage on intestinal Enterobacteriaceae was assessed with
semi-quantitative culture on agar with and without antibiotics on presentation and after 7
and 28 days.
Results
A total of 563 patients were enrolled between February 2009 and February 2010. Antibiotics
were prescribed for all except 2 of 563 patients. The majority were 2nd and 3rd generation
oral cephalosporins and amoxicillin with or without clavulanic acid. Respiratory viruses were
detected in respiratory specimens of 72.5% of patients. Antibiotic use was considered inap-
propriate in 90.1% and 67.5%, based on guidelines and detected pathogens, respectively.
On presentation parents reported antibiotic use for 22% of patients, 41% of parents did not
know and 37% denied antibiotic use. Among these three groups, six commonly used antibi-
otics were detected with HPLC in patients’ urine in 49%, 40% and 14%, respectively. Tem-
porary selection of 3rd generation cephalosporin resistant intestinal Enterobacteriaceae
during antibiotic use was observed, with co-selection of resistance to aminoglycosides and
fluoroquinolones.
Conclusions
We report overuse and overprescription of antibiotics for uncomplicated ARI with selection
of resistant intestinal Enterobacteriaceae, posing a risk for community transmission and per-
sistence in a setting of a highly granular healthcare system and unrestricted access to antibi-
otics through private pharmacies.
Registration
This study was registered at the International Standard Randomised Controlled Trials Num-
ber registry under number ISRCTN32862422: http://www.isrctn.com/ISRCTN32862422
Introduction
Antimicrobial resistance is a major threat to global health, sustainable development and the
global economy [1–3]. Globally, the number of deaths related to antimicrobial resistance is
predicted to increase from 700,000 currently to 10 million by 2050 without intervention [1]. In
the US and the EU, 23,000 and 25,000 deaths secondary to drug-resistant infections are esti-
mated to occur annually, respectively [4, 5]. These numbers are 3–5 times higher (relative to
population size) in Thailand, a middle-income country where antibiotic use is relatively well
controlled [6]. Figures are likely to be higher in settings with unrestricted access, a highly gran-
ular healthcare system and lack of antibiotic stewardship programmes like Vietnam, where
antibiotic usage and resistance rates are among the highest in Asia [7, 8].
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Antibiotics are commonly used or prescribed for mild acute respiratory infections (ARI) in
both children and adults in primary care. In the UK, for instance, a quarter of the population
visit their general practitioner for ARI annually, accounting for 60% of total GP antibiotic pre-
scribing [9, 10]. In Vietnam, the 14th most populous country globally and with a population of
90 million and a high infectious diseases burden, antibiotics are readily available over-the-
counter without prescription, including in community health posts and from private pharma-
cies [11]. Previous work has shown that 78% of antibiotics for human use were dispensed in
the 60,000 private pharmacies, of which around 90% without prescription, and that the most
common indication was for ARI (80%) [12]. In a cross-sectional study in northern Vietnam
75% of children under 5 had received antibiotics for an ARI in the preceding month, the large
majority dispensed without prescription in private pharmacies [13]. However, aetiological
studies show that ARIs are mostly caused by viruses and clinical trials have shown no efficacy
of antibiotics in treating conditions like acute bronchitis, bronchiolitis and (naso)pharyngitis
[14–17].
To inform policy and potential interventions, we aimed to quantify real life antibiotic pre-
scription rates compared with what was recommended from clinical guidelines and in relation
to detected pathogens in patients presenting with ARI at an outpatient clinic at a large tertiary
care paediatric hospital (Children’s Hospital 1) in Ho Chi Minh City, Vietnam. We also
assessed antibiotic use on presentation using questionnaires and HPLC detection of 6 fre-
quently prescribed antibiotics in urine (S1 Table), and the immediate impact of antibiotic
usage on selection of resistant intestinal Enterobacteriaceae using semi-quantitative culture.
Materials and methods
Patients and samples
Patients were enrolled at the respiratory infection examination rooms at the outpatient clinic
of Children’s hospital 1 (CH1) in Ho Chi Minh City, Vietnam. CH1 is a large tertiary referral
centre with an outpatient clinic with 54 examination rooms where 1,600,000 patients are seen
annually. At the 2 respiratory infection examination rooms, 45,000 patients are seen annually.
Patients are referred to the respiratory infection examination rooms when they register at the
outpatient department by nursing staff when presenting with respiratory symptoms as the
chief complaint. Patients were eligible for enrolment if they were under 16 years of age, had a
clinical diagnosis of ARI (defined as having an acute onset, within the last 5 days, of at least
one of the following symptoms as the chief complaint: cough, sore throat, runny nose or nasal
congestion), had no underlying illness (except asthma), were not admitted to hospital, and
agreed to return for a follow up visit after 1 week. After interim analysis of the first 100 patients
a strong increment in the proportions of resistant counted colonies was shown. A study
amendment was made and approved and the remaining patients to be enrolled were asked to
return after 4 weeks for an additional rectal swab to assess the duration of this effect. Patients
with a clinical diagnosis of sinusitis or acute otitis media were not enrolled. Written informed
consent was obtained from parents or legal guardians. Eligible patients were recruited by a
study doctor during a one-hour period on Mondays, Tuesdays, Wednesdays and Thursdays,
with weekly enrolment restricted to a maximum of 10 to 12 patients. Apart from follow-up vis-
its for study purposes, it was common for patients to return a number of times in the first
week after first presentation as part of standard outpatient care.
Demographic, clinical and antibiotic prescription and usage data were collected in case
report forms (CRF). Attending physicians assessed and recorded clinical diagnosis and out-
come. At enrolment combined nose and throat swabs (NTS) in Viral Transport Medium, a
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rectal swab in normal saline and a urine sample were collected. At follow-up visits after 1 week
and, in a subset of patients, after 4 weeks an additional rectal swab was collected.
Based on systematic reviews, local hospital guidelines and international guidelines antibiot-
ics were considered inappropriate based on clinical diagnosis if prescribed for a clinical diag-
nosis of uncomplicated ARI other than pneumonia or streptococcal pharyngitis/tonsillitis, and
based on clinical diagnosis and molecular diagnostic results if in addition to the clinical diag-
nosis a virus was detected (and no bacteria) [14–16, 18–20].
Ethics approval
Protocols and amendments were reviewed and approved by the Institutional Review Boards of
Children’s Hospital 1 and the Health Service of Ho Chi Minh City, and by the University of
Oxford Tropical Research Ethics Committee (OxTREC).
Molecular diagnostics
The following bacterial and viral pathogens were detected using inhouse molecular diagnos-
tics: Streptococcus pneumoniae, Haemophilus influenzae type b, Mycoplasma pneumoniae,
Legionella pneumophila, Chlamydophila pneumoniae and psittaci, Bordetella pertussis and
parapertussis, Influenza virus A-B, Parainfluenza virus 1–4, Respiratory Syncytial Virus A-B,
human metapneumovirus A-B, rhinoviruses, enteroviruses, parechoviruses, coronaviruses,
bocaviruses and adenoviruses. All assays were published previously, except the L. pneumophila
assay [21–28]. For L. pneumophila an inhouse validated assay, developed and used in the
Amsterdam University Medical Centres, was used. Nucleic acids were extracted using an auto-
mated commercial Guanidinium Thiocyanate (GuSCN) based method on the EasyMag (Easy
MAG 2.0, bioMérieux, Marcy l’Étoile, France) or MagnaPure 96 (Roche, Mannheim, Ger-
many) platform. Viral RNA was reversely transcribed using Superscript III reverse transcrip-
tase (Invitrogen, Carlsbad, California, USA) and random hexamers (Roche). Real-time PCR
was performed on a LC480 II Thermocycler (Roche). Primers were manufactured by Sigma
Proligo (Singapore). Probes containing Minor Groove Binders (MGB) were manufactured by
Applied Biosystems Inc. (Foster City, CA, USA), probes containing LCRED 610, 670 or
CYAN500 fluorophores or with incorporated Locked Nucleic Acid (LNA) residues were man-
ufactured by Tib Molbiol (Berlin, Germany), and probes containing only HEX or FAM by
Sigma Proligo. Equine Arteritis Virus and Phocid Herpes Virus were used as non-competitive
internal controls in PCRs with RNA and DNA targets, respectively [29, 30]. Testing was not
part of standard of care, was conducted batch-wise in a research laboratory and results were
not reported to the treating physicians.
Measurement of antibiotic levels in urine
Antibiotic levels in urine were determined using validated in-house protocols, as described
earlier [31]. The most frequently used antibiotics in the hospital and sold in the pharmacy of
Children’s Hospital 1 are listed in S1 Table. Briefly, urine concentrations of six frequently used
antibiotics (cephadroxil, cephalexin, cefaclor, cefixime, amoxicillin and cefuroxime) were
assessed using in-house validated High-Performance Liquid Chromatography (HPLC) proto-
cols. Briefly, HPLC was done on a Lachrom Elite–Hitachi HPLC controlled by EZChrom
v3.18 software (Merck–Hitachi Japan). Solid phase extraction was done using Isolute 96 fixed
well plates (Biotaga AB, Uppsala, Sweden). Separation was done through a 5μm LichroCart
240x4.6mm Purosphere RP-18/5μm 4x4 RP-18e for cephadroxil, cefaclor, cephalexin and
cefixime (limit of detection: 0.08mg/L; lower limit of quantification [LLOQ]: 0.3mg/L) and
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through a 5μm 125x4mm RP-8/5μm 4x4 RP-8e for amoxicillin and cefuroxime (LOD: 0.1mg/
L and 0.05mg/L, respectively; LLOQ: 0.2mg/L) [18].
Semi-quantitative culture of Enterobacteriaceae
Rectal swabs were kept at 4˚C and processed within 24 hours of collection. Swabs were sus-
pended in saline and serially diluted. Dilutions were cultured on MacConkey agar and the
dilution yielding between 20–200 colonies was made again the next day from the original spec-
imen for culture on MacConkey plates containing tetracycline (4 mg/L), amoxicillin (8 mg/L),
amoxicillin-clavulanic acid (8–4 mg/L), ceftazidime (2 mg/L), ciprofloxacin (1 mg/L), trimeth-
oprim/sulfamethoxazole (2/38 mg/L), gentamicin (4 mg/L), meropenem (4 mg/L) and a con-
trol plate without antibiotics. The concentrations used were selected based on the CLSI criteria
for intermediate susceptibility of these antibiotics for Enterobacteriaceae. Pan-susceptible and
resistant ATCC isolates were used as internal quality controls for each batch of plates. Lactose
fermenting Enterobacteriaceae were identified as large circular smooth pink colonies by expe-
rienced clinical microbiology laboratory technicians and were counted. For each antibiotic the
proportion of resistant Enterobacteriaceae was determined as the ratio of bacterial counts on
plates with and without different antibiotics. Only pink (lactose fermenting) colonies were
counted and throughout this manuscript when we refer to Enterobacteriaceae counts, lactose
fermenting Enterobacteriaceae are meant. Bacterial counts (+1) were logarithmically trans-
formed for display in graphs and regression was used to calculate the position of lines repre-
senting the mean for each collection timepoint. This semi-quantitative method was designed
to be a simple and elegant way to show relative selection / enrichment of resistant easily cultur-
able relevant human pathogens during appropriate or inappropriate use of antibiotics for an
infection in a different body compartment.
Statistical analysis
All variables of interest were summarised by group (age, clinical diagnosis, single infection or
co-infection). For descriptive statistics, prevalence and percentage were used for categorical
variables while mean and standard deviation or median and interquartile range (IQR) were
used for normally or non-normally distributed continuous data, respectively. Comparisons of
epidemiological and clinical characteristics among age groups or infection groups (no patho-
gen, one viral infection, one bacterial infection and co-infection) were analysed using Fisher’s
exact test for categorical data and the Kruskal-Wallis test for continuous data. Differences of
proportions of resistant Enterobacteriaceae colonies between days 1 and 8, and days 8 and
week 4 were assessed using the Wilcoxon matched pairs signed-rank test. In order to assess
concordance of antibiotic use as determined by parent interviews and urine tests, a Kappa
measure of agreement was used. All statistical tests were performed as two-tailed tests at 5%
significance levels. SPSS version 20 was used for all analyses.
Results
Demographic and clinical data
Between February 2009 and February 2010 563 patients were enrolled, 545 returned for a fol-
low-up visit at day 8, 13 were followed-up by telephone and 5 were lost to follow-up. Fig 1
shows a flowchart of enrolment and follow-up. Demographics, clinical diagnoses and outcome
are displayed in Table 1. Patients had a median age of 1.96 years (IQR 1.05–3.18) and 95.2% of
patients were aged 5 years or below. The male: female ratio was 1.28:1. Complete or partial
recovery at day 8 according to the attending physician was reported for 138/563 (24.5%) and
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361/563 (64.1%) patients, respectively. In contrast, 59/563 (10.5%) patients did not recover:
6.4% remained clinically unchanged, 2.8% worsened and 1.2% were admitted to hospital. By
proportion of fully recovered patients at day 8, upper respiratory infections had a better out-
come than lower respiratory tract infections (34% [53/155] vs. 21% [81/391]) and, similarly,
bronchitis had a worse outcome than other clinical diagnoses (20% [53/262]).
Prescription of antibiotics and other medications
Antibiotics were prescribed for all but two patients (561/563, 99.6%), with a median duration
of 6 days (IQR: 4–7). The most commonly prescribed antibiotics at presentation were amoxi-
cillin-clavulanic acid (45.6%), cefuroxime axetil (22.0%), cefixime (11.4%), cefaclor (8.2%),
erythromycin (3.7%), amoxicillin (3.0%), and cefpodoxime (2.3%). First choice antibiotics for
ambulatory pneumonia treatment as recommended by the 2009 hospital guidelines, i.e. amoxi-
cillin or co-trimoxazole, were infrequently prescribed (3.0 and 0.4%, respectively).
In addition to antibiotics, cough syrup (394/563, 70.0%), bronchodilators (324/563, 57.6%),
antipyretics (150/563, 26.6%), antihistamines (66/563, 11.7%), mucolytics (62/563, 11.0%) and
steroids (58/563, 10.3%) were also prescribed.
Pathogen detection rates and associations
Detection of viral and bacterial pathogens using molecular assays is shown in Table 2. S. pneu-
moniae and H. influenzae type b were detected in 553/563 (98.4%) and 69/563 (12.3%) NTS
samples from patients (Table 2). Results for these two bacteria were not included in further
analyses (see discussion).
Fig 1. Enrolment flowchart. Flowchart of enrolment and follow-up of 563 patients with acute respiratory infection enrolled at the
outpatient department of Children’s Hospital 1, Ho Chi Minh City, Vietnam.
https://doi.org/10.1371/journal.pone.0241760.g001
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Viruses were detected in 410/563 (72.8%) NTS samples, 294/410 (71.7%) were single infections
and 116/410 (28.3%) were co-infections with either viruses or bacteria. Atypical bacteria and Borde-
tella spp. were detected in 43/563 (7.6%) samples, in most of which (27/43, 63%) viruses were also
detected. Most commonly detected viruses were rhinoviruses (27%, 152/563) and enteroviruses
(10.5%, 95/563). M. pneumoniae was the most frequently detected atypical bacterium (4.4%, 25/563).
Among patients older than five, a pathogen was detected in only 40% (11/27), as opposed to
80–90% in the<1, 1 and 2–5 age groups.
Detections by month of viral and atypical bacterial pathogens are shown in S1 Fig. Detection
rates of pathogens varied from month to month during the year and clear seasonal patterns
were observed for several viruses. Influenza virus A, Respiratory Syncytial Virus (RSV) and
human metapneumovirus (hMPV) were mostly seen during and around the rainy season (June
to November) with hMPV peaking after RSV, Parainfluenzavirus 3 (PIV3) was mostly detected
from November to June. Enteroviruses and Rhinoviruses were detected throughout the year,
with highest detection rates for Enteroviruses in November and for Rhinoviruses in March.
Significant associations between specific pathogens and clinical diagnosis or outcome were
not observed, but co-infections and infections with multiple viruses were associated with a
worse outcome.
Table 1. Patient baseline, diagnosis and outcome data.
Characteristicsa ARI patients (n = 563)
Median age in years (IQR) 1.96 (1.05–3.18)
� 1 year, n (%) 137 (24.3)
1-� 2 years, n (%) 148 (26.3)
2-� 5 years, n (%) 251 (44.6)
>5 years, n (%) 27 (4.8)
Male, n (%) 316 (56.1)
Clinical diagnosisb
asthma 17 (3.0)
bronchitis 262 (46.5)
bronchiolitis 122 (21.7)
pneumonia 7 (1.2)
nasopharyngitis 105 (18.7)
pharyngitis 42 (7.5)
tonsillitis 7 (1.2)
laryngotracheobronchitis 1 (0.2)
Outcomec
Complete recovery 138 (24.5)
Partial recovery 361 (64.1)
Unchanged 36 (6.4)
Worsened 16 (2.8)
Admitted 7 (1.2)
Unknown 5 (0.9)
a Baseline characteristics of 563 patients with acute respiratory infection enrolled at the outpatient department of
Children’s Hospital 1, Ho Chi Minh City, Vietnam
b Clinical diagnosis of 563 patients with acute respiratory infection enrolled at the outpatient department of
Children’s Hospital 1, Ho Chi Minh City, Vietnam
c Outcome recorded at day 8 of 563 patients with acute respiratory infection enrolled at the outpatient department of
Children’s Hospital 1, Ho Chi Minh City, Vietnam.
https://doi.org/10.1371/journal.pone.0241760.t001
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Among the detected viruses, several are known to also be frequently detected among
asymptomatic children, whereas influenza virus A and B, RSV, hMPV and PIV3 have stronger
associations with disease and outbreaks of respiratory infections. These 4 were detected in
186/563 (33.0%) patients (influenza A 39, B 5, RSV 54, hMPV 41, PIV3 46, RSV + hMPV 1).
Appropriateness of antibiotics according to guidelines and pathogens
We retrospectively classified antibiotic use as inappropriate based on clinical diagnosis and
(RT-)PCR results. We used two definitions for inappropriate antibiotic use: 1) based on clini-
cal diagnosis, i.e. antibiotic use in patients who were not diagnosed with pneumonia or phar-
yngitis/tonsillitis and 2) based on a combination of clinical and laboratory diagnosis in
patients whose respiratory samples were positive for at least one of 14 viruses and negative for
6 bacterial pathogens tested by PCR (excluding S. pneumoniae and H. influenzae).
Table 2. Pathogens detected in respiratory samples.
ARI patients
(n = 563)
Viruses
Influenza virus A, n(%) 39 (6.9)
Influenza virus B, n(%) 5 (0.9)
Enterovirus A-D, n(%) 59 (10.5)
Adenovirus, n(%) 52 (9.2)
Rhinovirus A-C, n(%) 152 (27.0)
RSV A/B, n(%) 54 (9.6)
Human metapneumovirus, n(%) 41 (7.3)
Parainfluenza virus 1, n(%) 10 (1.8)
Parainfluenza virus 2, n(%) 11 (2.0)
Parainfluenza virus 3, n(%) 46 (8.2)
Parainfluenza virus 4, n(%) 19 (3.4)
Coronaviruses, n(%) 21 (3.7)
Human parechovirus, n(%) 4 (0.7)
Human bocavirus, n(%) 19 (3.4)
Bacteria
Haemophilus influenzae, n(%) 69 (12.3)
Streptococcus pneumoniae, n(%) 553 (98.4)
Bordetella pertussis, n(%) 4 (0.7)
Bordetella parapertussis, n(%) 11 (2.0)
Legionella pneumophila, n(%) 0 (0)
Mycoplasma pneumoniae, n(%) 25 (4.4)
Chlamydophila pneumoniae, n(%) 3 (0.5)
Chlamydophila psitacci, n(%) 0 (0)
Any pathogen positive, n(%) 426 (75.6)
Single viral infection, n(%) 294 (52.2)
Single bacterial infection, n(%) 16 (2.8)
Co infection, n(%) 116 (20.6)
No pathogen, n(%) 137 (24.3)
Viral and bacterial pathogens detected by real-time multiplex or single (RT-)PCR in pooled nasal and pharyngeal
swabs taken at enrolment among 563 patients with acute respiratory infection enrolled at the outpatient department
of Children’s Hospital 1, Ho Chi Minh City, Vietnam.
https://doi.org/10.1371/journal.pone.0241760.t002
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Only 7 (1.2%) patients had a clinical diagnosis of pneumonia and 49 (8.7%) patients had a
diagnosis of pharyngitis or tonsillitis (Table 1). The remaining ninety percent (90.1%, 507/563)
of patients received antibiotics inappropriately according to definition 1. First choice antibiot-
ics for ambulatory pneumonia treatment as recommended by the 2009 hospital guidelines, i.e.
amoxicillin or co-trimoxazole, were rarely prescribed (3.0 and 0.4%, respectively). Among
these 507 patients, 380 had a virus and no atypical bacteria detected, and therefore, according
to definition 2, 67.5% (380/563) of patients received antibiotics inappropriately.
Antibiotic use on presentation by questionnaire and by detection in urine
by HPLC
Results from parent interviews on antibiotic use and HPLC detection in urine collected at pre-
sentation are shown in Tables 3 and 4. From 553/563 (98.2%) patients a urine sample was col-
lected at presentation. Antibiotic use during the two days prior to enrolment was reported by
123/553 (22.2%) of parents, 206/553 (37%) reported no antibiotic use and 224/553 (40.5%) did
Table 3. Antibiotic use assessed by questionnaire and HPLC.
HPLC (%) Questionnaire (%) of which HPLC positive
(total number = 553) (total number = 553)
Any antibiotic (patients) 178 32.2 123 22.2 60
1 antibiotic 160 28.9 119 21.5
2 antibiotics 14 2.5 4 0.7
3 antibiotics 4 0.7
Total (antibiotics) 200 127
Per antibioitc
Amoxicillin (with or without clavulanic acid) 52 9.4 48 8.7 22
Cefaclor 28 5.1 37 6.7 12
Cefadroxil 34 6.1 3 0.5 3
Cefixime 54 9.8 14 2.5 8
Cefuroxime 10 1.8 16 2.9 4
Cephalexin 22 4.0 1 0.2 1
Other 8 0.2
Total (antibiotics) 200 127 60
Negative (below the level of detection) 375 67.8
Denied use 206 37.3 29
Unknown 224 40.5 89
Antibiotic use among 553 patients with acute respiratory infection prior to enrolment at the outpatient department of Children’s Hospital 1, Ho Chi Minh City,
Vietnam as assessed by questionnaire on enrolment and by HPLC of urine collected on enrolment.
https://doi.org/10.1371/journal.pone.0241760.t003
Table 4. Kappa score.
Kappa 0.37 questionnaire
+ -
HPLC + 60 29 89
- 63 177 240
123 206 329
Kappa score of antibiotic use as assessed by questionnaire on enrolment and by HPLC of urine collected on
enrolment.
https://doi.org/10.1371/journal.pone.0241760.t004
PLOS ONE Antibiotic use in outpatients in Vietnam
PLOS ONE | https://doi.org/10.1371/journal.pone.0241760 November 4, 2020 9 / 18
not know. Among patients from whom a urine sample was collected, 32% (178/553) had a pos-
itive result for one of 6 frequently prescribed antibiotics detected by HPLC in urine; 2 different
antibiotics were detected in 14 patients and 3 in 4 patients (Table 3). Cefixime, a third-genera-
tion oral cephalosporin, was the most frequently detected antibiotic.
Among those who confirmed or denied antibiotic use, there was agreement with HPLC
results in 237/329 (72%; kappa score 0.37 [0.21–0.40: fair agreement], Table 4). Antibiotics
were detected in urine of 29/206 (14%) patients whose parents denied use, and in 60/123
(49%) patients for whom use was reported, with the measured antibiotic corresponding to
the reported antibiotic in 50/60 (83%) of cases. Use of the 6 tested antibiotics was reported
in 56 of the remaining 63 (89%) cases that tested negative. In patients for whom prior use
was unknown, antibiotics were detected in 89/224 (40%). The sensitivity of HPLC to detect
6 antibiotics in urine from patients whose parents reported use of these same 6 antibiotics,
was 49%.
Effect of antibiotics on intestinal Enterobacteriaceae
We determined the proportion of patients carrying resistant Enterobacteriaceae and the frac-
tion of antibiotic resistant intestinal Enterobacteriaceae by semi-quantitative culture of rectal
swabs taken on day 1 (n = 563) and 8 (n = 542) on 9 MacConkey agar plates each: with and dif-
ferent antibiotics (tetracycline, amoxicillin, amoxicillin-clavulanic acid, ceftazidime, ciproflox-
acin, trimethoprim/sulfamethoxazole, gentamicin, meropenem). Thirty-five of 40 consecutive
invited patients came back to hospital after 4 weeks for re-assessment of intestinal Enterobac-
teriaceae, after interim analysis of the first 100 patients had shown strong increments of the
proportion of patients carrying resistant bacteria and the proportions of resistant bacteria in
their samples (Fig 2). Proportions of patients and proportions of counted resistant colonies are
shown in Table 5. McNemar test and Wilcoxon matched pairs signed-rank tests were used to
assess statistical significance of different proportions of patients and resistant colonies, respec-
tively. Log transformed colony counts at 3 different timepoints on plates with and without 4
different antibiotics (amoxicillin, ceftazidime, gentamicin, and ciprofloxacin) are shown in Fig
2. Regression was used to calculate the position of lines representing the mean.
The proportion of patients from whom antibiotic resistant Enterobacteriaceae were cultured
on 8 plates containing different antibiotics and the proportion of counted resistant Enterobac-
teriaceae colonies (defined as the ratios of the number of colonies on 8 different plates contain-
ing 8 different antibiotics divided by the number of counted colonies on 1 plate without
antibiotics) among 563, 542 and 35 patients with acute respiratory infection enrolled at the
outpatient department of Children’s Hospital 1, Ho Chi Minh City, Vietnam at day 1, day and
day 28 of enrolment. McNemar test and Wilcoxon matched pairs signed-rank tests were used
to assess statistical significance of different proportions of patients and resistant colonies,
respectively.
For most antibiotics, the proportions of patients carrying resistant bacteria were already
high at day 1. These proportions further increased significantly at day 8 for amoxicillin, amoxi-
cillin with clavulanic acid, ceftazidime, ciprofloxacin and gentamicin, and restored to baseline
proportions or below after 4 weeks. Similarly, the proportions of resistant intestinal Enterobac-
teriaceae colonies increased for these 5 antibiotics and returned to day 1 levels after 4 weeks
(Table 5 and Fig 2). For ceftazidime and co-trimoxazole the proportions of resistant Enterobac-
teriaceae colonies were significantly lower after 4 weeks compared to day 1, which may be
explained by antibiotic use before presentation. Indeed, when excluding patients who were
already using antibiotics on day 1 (assessed by questionnaire or HPLC), proportions of resis-
tant Enterobacteriaceae colonies after 4 weeks were similar to those at day 1.
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Discussion
According to systematic reviews and current international and local guidelines, including
those in place at the recruiting hospital, only clinical diagnoses of pneumonia and streptococ-
cal pharyngitis/tonsillitis are indications for prescription of antibiotics in outpatients with ARI
[14–16, 18–20]. Antibiotics have not been proven effective and therefore are not recom-
mended for other diagnoses unless there are bacterial super-infections, but these have been
reported to occur in only around 5–8% of children with ARI [32, 33]. In our study, pneumonia
and pharyngitis/tonsillitis were diagnosed in only 1.2% (n = 7) and 8.7% (n = 49) of patients
presenting with ARI, but antibiotics were prescribed in all but two patients enrolled. This
means that more than 90% of patients inappropriately received antibiotics for clinical diagno-
ses, which do not require antibiotic treatment according to treatment guidelines. Using more
stringent criteria, based on detection of viral and bacterial pathogens (although tested retro-
spectively in this study), nearly 70% of patients were inappropriately treated with antibiotics, i.
Fig 2. Gut Enterobacteriaceae grown on plates with and without antibiotics. Logarithmically transformed colony counts of
Enterobacteriaceae on MacConkey agar with (y-axis) and without (x-axis, MC) antibiotics from rectal swabs taken on day 1 (n = 563, blue),
day 8 (n = 542, red) and day 29 (n = 35, black) from patients with acute respiratory infection enrolled at the outpatient department of
Children’s Hospital 1, Ho Chi Minh City, Vietnam. Red, blue and black lines represent the mean as determined by regression analysis.
https://doi.org/10.1371/journal.pone.0241760.g002
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e. when only a viral pathogen was detected. Moreover, the choice of antibiotics rarely followed
hospital guidelines, but instead broad-spectrum agents, such as amoxicillin-clavulanic acid
and second or third generation cephalosporins were prescribed which are not recommended
for ARIs.
In addition to high rates of inappropriate antibiotic prescription by attending physicians,
antibiotics were also frequently used prior to presentation. Interviewed parents reported anti-
biotic use before presentation in 22% of children, while 41% of parents did not know whether
antibiotics were used. As determined by HPLC detection of antibiotics in urine, the rate of
prior use was 32% with fair agreement between reported and detected antibiotics (Table 4).
HPLC may provide a more accurate and objective detection rate of antibiotic use than the
questionnaire, although sensitivity is limited and HPLC only detects antibiotics several hours
after use. Antibiotics were detected by HPLC in only 49% of samples from patients whose
parents reported antibiotic use. If we extrapolate this, we can then also assume that the antibi-
otic use among patients whose parents didn’t report or weren’t sure about antibiotic use is in
reality also approximately twice as high as detected with HPLC: 28% and 80%, respectively, or
a total of 65% of patients who had used antibiotics before presentation. These high reported,
measured and estimated rates of antibiotic use reflect the over-the-counter availability and
widespread use of antibiotics in Vietnam.
High rates of antibiotic use in outpatient children with ARI have been reported before, par-
ticularly in Asian countries, with rates ranging from 30% in the UK to around 80% in China
and Korea [34–36]. Although differences may be partially explained by the use of different def-
initions and differences in study populations, they support our observed high level of antibiotic
overuse in Vietnamese children. A high rate of antibiotic consumption in Vietnamese children
was also suggested by a community survey in northern Vietnam where 73% of interviewed
parents indicated that their children between 1–5 years old had used antibiotics in the preced-
ing month [13].
That high usage of antibiotics is not without consequences was shown by the selection of
antibiotic-resistant Enterobacteriaceae in stool samples of our patients. The proportions of
Table 5. Proportions of patients with resistant Enterobacteriaceae and proportions of resistant Enterobacteriaceae at different timepoints.
Proportion of children carrying resistant bacteria Day 1 (n = 563) Day 8 (n = 542) Day 28 (n = 35) p1 (Day 1 vs 8) p2 (Day 1 vs 28)
Amoxicillin, n (%) 513 (91.1) 516 (95.2) 28 (80.0) 0.008 0.5
Amoxicillin—Clavulanic acid, n (%) 504 (89.5) 513 (94.7) 28 (80.0) 0.001 1
Ceftazidime, n (%) 379 (67.3) 446 (82.3) 13 (37.1) <0.001 0.2
Ciprofloxacin, n (%) 322 (57.2) 361 (66.6) 20 (57.1) <0.001 0.2
Gentamicin, n (%) 333 (59.1) 377 (69.6) 19 (54.3) <0.001 0.3
Tetracycline, n (%) 516 (91.7) 498 (91.9) 29 (82.9) 1 0.5
Cotrimoxazole, n (%) 524 (93.1) 513 (94.6) 25 (71.4) 0.4 0.3
Meropenem, n (%) 4 (0.7) 2 (0.4) 0 (0) 0.7 NA
Proportion of resistant bacteria
Amoxicillin, n (%) 0.84 0.94 0.79 <0.001 0.06
Amoxicillin—Clavulanic acid, n (%) 0.82 0.92 0.82 <0.001 0.87
Ceftazidime, n (%) 0.50 0.70 0.29 <0.001 0.005
Ciprofloxacin, n (%) 0.40 0.50 0.44 <0.001 0.1
Gentamicin, n (%) 0.41 0.52 0.44 <0.001 0.7
Tetracycline, n (%) 0.82 0.84 0.83 0.36 0.28
Cotrimoxazole, n (%) 0.85 0.89 0.68 0.054 0.02
Meropenem, n (%) 0.004 0.002 0 0.5 0.3
https://doi.org/10.1371/journal.pone.0241760.t005
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patients carrying resistant bacteria as well as the proportions of resistant Enterobacteriaceae
colonies in stools of individual patients to commonly used antibiotics were already high at pre-
sentation but showed further significant increases at day 8. This included Enterobacteriaceae
resistant to aminoglycosides or quinolones, representing drugs that were not frequently pre-
scribed for ARI, presumably reflecting the presence of multiple resistance genes on mobile
genetic elements such as plasmids. The significant increase in resistant bacteria under antibi-
otic pressure may lead to increased transfer of resistance genes to other commensal or patho-
genic bacteria, and to person-to-person spread in the community through faecal-oral
transmission. After withdrawing antibiotics, we observed restoration to baseline values of pro-
portions of resistant Enterobacteriaceae colonies for all antibiotics tested. Proportions of Enter-
obacteriaceae colonies resistant to ceftazidime and co-trimoxazole were restored to below
baseline values, which may be explained by antibiotic use before presentation. While these
observations suggest that immediate effects of antibiotic treatment on selection of resistant
bacteria are only short-lived, long-term persistence of selected resistance genes has been
shown in other studies [37–42]. Given the widespread use of antibiotics in Vietnam, the selec-
tion, persistence and transmission of resistant bacteria likely occurs on a large scale at commu-
nity levels, as is also indicated by the high prevalence of resistance at presentation in our
outpatients.
We acknowledge there were a number of limitations to this work, e.g. clinical diagnoses
were not assessed and recorded in a systematic and standardized way. Although we acknowl-
edge this may be seen as a limitation, our work reflects the real life day-to-day practice in the
busy outpatient clinics of a paediatric hospital and representative high antibiotic prescription
rates. Results presented here may not be generalisable to countries where there is no over-the-
counter availability of antibiotics. Other limitations may have been:
1. Attending physicians recorded clinical diagnoses at their discretion without the use of exact
case definitions. Theoretically, doctors may have over-diagnosed conditions as pneumonia
to justify antibiotic prescriptions, although this did not seem to have occurred.
2. We did not record any laboratory values that are markers of bacterial infection like white
blood cell count and C-reactive protein. This is not routinely done in the outpatient clinics
where patients were recruited and results would have influenced the observational nature
of this study.
3. The CRF we used did not specifically record (warning signs of) complications as mentioned
in some guidelines, e.g. NICE criteria for complications or Centor criteria for streptococcal
pharyngitis [43, 44].
4. We used the respiratory examination rooms for recruitment where the relatively more
severe cases of respiratory infections are seen. This may have selected for a patient popula-
tion more likely to receive antibiotics.
5. Common childhood bacterial pneumonia pathogens S. pneumoniae and H. influenzae type
b were not optimally diagnosed in this study. Respiratory infection with these pathogens
should be assessed using wet and Gram-staining and bacterial culture of sputum, which
was not performed here. Molecular testing results were not taken into account when
describing aetiology as these results were considered to include colonisation, and in the
case of S. pneumoniae potentially cross-reactivity. High carriage rates of S. pneumoniae up
to 80% have been reported in children in the region, but we didn’t find report of rates as
high as found in our cohort [45, 46]. Our PCR assay for S. pneumoniae targeted the pneu-
molysin gene [21]. This gene is a virulence factor and expressed by almost all isolates of S.
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pneumoniae. However, recent reports also showed that other species of Streptococcus can
also express this gene [47, 48]. Our assay was developed for use in diagnosis of central ner-
vous system infections in otherwise sterile cerebrospinal fluid. It is not unlikely that when
used in respiratory swabs cross-reactivity with other oral streptococci may occur. We fur-
ther justified disregarding these results because we detected these bacteria at similar rates in
NTS samples from a cohort of healthy children (unpublished data). The bacterial load, as
expressed by Cp value for S. pneumoniae was significantly higher in patients than in healthy
children, however, this did not correlate with disease, disease severity, or whether other
pathogens were detected. We hypothesized that this higher load, which has also been
observed in other studies, was caused by increased secretions and shedding of (colonized)
nasopharyngeal epithelial cells and results for these two bacteria were not included in this
analysis [49].
We show that in a setting of unrestricted access to antibiotics and non-adherence to clinical
guidelines there is an alarmingly high inappropriate use of antibiotics for children with mild
self-limiting illness, before visiting the outpatient clinic and prescribed by doctors in the out-
patient clinic. This situation is similar in many low- and middle-income countries across Asia
and Africa [50]. We also show that taking antibiotics exerts strong but reversible selective pres-
sure on intestinal Enterobacteriaeceae.
Physicians report that they prescribe antibiotics because of a lack of diagnostic tools to help
discriminate between bacterial and viral infections. Laboratory capacity building, including
classical microbiology and molecular testing for viruses could help provide this information
for more severe patients and inpatients within hours to days, which is too slow for outpatients.
Point-of-care testing for 4 common viruses associated with ARI (Influenza virus A and B,
RSV, hMPV and PIV-3) might have prevented antibiotic prescription in 186/563 (33%) of our
patients, assuming good sensitivity and adherence. Likewise, use of a rapid CRP test could
help distinguish viral from bacterial infections and reduce antibiotic prescription rates signifi-
cantly, as was recently shown in a study in northern Vietnam [51].
In 2013, Vietnam established a National Action Plan for AMR of which, similar to the WHO
Global Action Plan, key components are to raise public awareness, to strengthen and improve
national surveillance on antibiotic use and susceptibility, to ensure adequate supply of quality
antibiotics, to promote the proper and safe use of antibiotics in humans, livestock, poultry and
aquaculture and to promote infection control [52]. Based on our observations, and more recent
surveillance studies on antimicrobial resistance in Vietnam, we propose that Vietnam’s strategy
for AMR should, besides enhancement of laboratory support, include a focus on intensive and
continued medical training (CME) in rational antibiotic use for medical students and certified
medical staff including physicians and development and implementation of antibiotic steward-
ship programmes and treatment guidelines at all levels of the healthcare system, similar to but
more extensive than what published in a recent study [53]. It is crucial to involve commercial
pharmacies in this plan, as 80% of antibiotics for human use are dispensed in the 60.000 phar-
macies in Vietnam (of which 90% without prescription) and these are dependent on antibiotic
sales for 25% of their revenue [12]. The general Vietnamese public should be engaged through
educational programmes through national media and in the communities. At government level,
existing legislation on prescription-only drugs should be enforced and expanded to assure that
antibiotics can no longer be purchased without a doctor’s consultation.
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outpatient department of Children’s Hospital 1, Ho Chi Minh City, Vietnam. X-axis: month;
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S1 Table. Prescribed antibiotics. (a) List of most frequently prescribed antibiotics in the out-
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